Prelude Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-91,250	Closed	-$758K	–	1300
2024 Q3	$758K	Buy	+91,250	New	+$758K	0.05%	414
2023 Q2	–	Sell	-10,968	Closed	-$154K	–	1163
2023 Q1	$154K	Sell	10,968 -1,500	-12%	-$21K	0.01%	809
2022 Q4	$178K	Buy	+12,468	New	+$178K	0.01%	861